STM publisher Elsevier, Netherlands, has announced the availability of a new version of Reaxys, which offers a refined user interface with new search functionality that facilitates queries and expedites research.
Using Reaxys, chemists can more easily find relevant and reliable answers without having to learn how to design complex queries. Built by chemists for chemists, the design of Reaxys reflects how users search for answers and the context of the terms they use.
Features of the new search tool include.
Ask Reaxys: allows users to search by keyword phrase via a search bar that reflects the simplicity of internet searches. Reaxys search algorithms return the most appropriate result from documents, compounds, reactions or properties.
ReaxysTree: allows users to browse the Reaxys bibliographic content using a familiar, tree-like visualisation of the data organisation, facilitating the discovery of previously unknown connections and the ability to generate new ideas.
Formula Builder: supports users in creating complex queries for inorganic and organometallic substances more easily.
Reaxys customers were automatically upgraded to the new version on April 14th.
The Intellectual Property & Science business of Thomson Reuters has released its annual forecast of the drugs to watch in 2014, including three potential blockbuster treatments anticipated to attain more than $1 billion in sales through 2019, after entering the marketplace this year.
The study utilised CortellisTM Competitive Intelligence, the pharmaceutical industry's source for drug pipeline, deals, patents, and company content, to create a Market Insight report identifying drugs that will have significant impact on the marketplace in 2014 and for years to come.
The analysis points to three potential blockbuster drugs include Sovaldi: Gilead's oral NS5B ploymersase inhibitor for treating hepatitis C virus (HCV) was approved by the FDA in December 2013 and is expected to reach a consensus of $2.4 billion in sales in 2014, rising to its peak in sales of an estimated $9.1 billion in 2017.
Anoro Ellipta: GlaxoSmithKline/Theravance's Anoro Ellipta, which contains two bronchodilators for the long-term, once-daily maintenance treatment of airflow obstruction in patients with Chronic Obstructive Pulmonary Disease (COPD), which is predicted to outsell its developers' 2013 potential blockbuster Relovair in the COPD field, with forecasted sales of $3 billion through 2019.
Idelalisib: Gilead filed this oral P13K p110-delta subunit inhibitor for US approval for indolent non-Hodgkin's lymphoma in September 2013 and for European approval for chronic lymphocytic leukemia (CLL) and INHL in October 2013. A US filing for CLL is also planned. This treatment demonstrated significant efficacy in a phase III CLL trial; however, idelalisib faces stiff competition in the CLL marketplace.
Among those worthy of additional attention are Eli Lilly's long-acting GLP-1 analog dulaglutide for diabetes and its anti-VEGFR2 mAb Cyramza for gastric cancer, as well as MannKind's inhaled insulin product Afrezza. This will be the third filing for Afrezza since 2009, after the FDA twice requested further information.
The Thomson Reuters Market Insight report also includes an update on the 2013 Drugs to Watch, including Vascepa (Amarin), Pomalyst (Celgene), Kadcyla (Roche), and Relovair (GlaxoSmithKline, Thervance).
Information and point-of-care solutions provider Wolters Kluwer Health, US, has called upon healthcare organisations to view deferment of the ICD-10 implementation as an opportunity to refine plans to further minimise post-transition impacts and maximise quality and financial outcomes. In particular, the delay provides more time for clients to expand current strategies and further leverage its Health Language® and ProVation® Medical solutions to build a solid foundation for long-term clinical, financial and operational success under the expansive new code set.
Authorised on April 1 as part of broader Sustainable Growth Rate legislation, the ICD-10 implementation deadline was pushed back to at least October 2015. While the delay was met with relief by organisations that were struggling to comply with multiple concurrent regulatory mandates, even those that were on track to meet the original ICD-10 deadline can leverage the additional time to refine plans to minimise anticipated impacts on productivity and reimbursements to more fully realize cost and quality improvements.
To ensure ICD-10 readiness, healthcare organisations are encouraged to leverage Health Language solutions and expertise to support the key aspects of transition planning. The planning includes protecting the revenue cycle; ensuring a clinically complete translation; preparing for post-ICD-10 updates; and optimising clinical workflow.
Finally, healthcare organisations are encouraged to automate documentation and coding by implementing a structured reporting solution such as ProVation® MD, which has been enabled for ICD-10 for more than a year. ProVation MD captures the granularity required under ICD-10 by guiding physicians to document at the appropriate level of specificity. The proper CPT® and ICD-10 diagnosis codes are then automatically applied, producing clinically-appropriate, coder-ready procedure notes at the point of care.
STM Publisher World Scientific has announced the launch of Journal of Extreme Events. The objective of the journal is to provide a forum for analysis of the occurrence, impact, and significance of extreme events on natural and human systems. The Journal will provide a range of opportunities for manuscripts including original research papers, review assessments, and science-policy statements. Readership for the journal will come from a range of academic disciplines as well as research-oriented practitioner and stakeholder professions.
Journal content, although not exclusively, will focus on extreme weather and climate events and their connections with natural and human system processes. The study of other types of extreme events will be examined as they relate to and inform understanding of local and global environmental changes and their implications.
Main thematic areas of the Journal will include conditions, drivers and impacts of extreme events on the natural systems and human systems; conditions, drivers and impacts of extreme events on coupled human and natural systems; extreme events as surprises and associated uncertainty; indicators and monitoring of extreme events and early warning systems; and scalar aspects of extreme events - local, regional, and global dimensions.
Others include risk analysis and social learning from extreme events in the context of climate non-stationarity; exposure and vulnerability to extreme events; extreme events and system transitions; and resilience to extreme events, and sustainability and transformation.
ACCUCOMS, a Netherlands-based provider of sales and marketing services for publishers, has announced the date and location of its annual event, ACCUFEST. This event brings together the company's current customer base as well as academic publishers interested in ACCUCOMS' services.
The year 2014 marks the third annual ACCUFEST event to be held in Heidelberg, Germany on the 5th and 6th of October. The idea behind this two-day event is to bring together publishers to inform them of current trends in scholarly publishing, mature and emerging markets, and ACCUCOMS' services.
Publishers will have a chance to listen to talks by keynote speakers who are experts in the field of information management and research. One-on-one discussions with regional sales representatives from ACCUCOMS will also be possible. In addition to the informative talks and market analysis and forecasts, there is an exciting evening program planned. ACCUFEST also importantly takes place a few days before the Frankfurt Book Fair (8th – 12th October), so publishers are urged to attend both events. The company equally represents its publishers at the book fair.
This course has been designed as a follow-on from Journal Development 1 which provides participants with a toolbox system for planning the development of their journals. This more senior course looks at overarching strategies for journal development (including acquisition and portfolio development). The course is built around case studies to allow participants to work on simulated scenarios in order to discuss and test ideas and strategies with their peers and the course facilitators.(full day)
Event Date: December 3, 2013
Projects are fundamental to all publishing organisations. Everyone gets involved in them. They may involve developing new products, new processes and systems, adopting new technologies, reaching new markets, acquiring new business, selecting new suppliers or improving existing processes. Projects are also challenging and often fail to achieve the desired results. This course provides a template and many supporting tools that can be applied to all projects, large or small, to help ensure successful outcomes. It has a strong emphasis on getting things right at the outset because this is where most problems with projects arise. The course tutors are practising project managers with a wealth of experience from the publishing sector. The programme is highly practical and includes break-out sessions using real project scenarios provided by delegates as well as providing publishing case studies as examples of what works and what doesn't. It provides an excellent introduction for those new to taking responsibility for projects as well as a great refresher for those facing new project challenges. (full day)
Event Date: November 26, 2014
Projects are fundamental to all publishing organisations. Everyone gets involved in them. They may involve developing new products, new processes and systems, adopting new technologies, reaching new markets, acquiring new business, selecting new suppliers or improving existing processes. Projects are also challenging and often fail to achieve the desired results. This course provides a template and many supporting tools that can be applied to all projects, large or small, to help ensure successful outcomes. It has a strong emphasis on getting things right at the outset because this is where most problems with projects arise.
The course tutors are practising project managers with a wealth of experience from the publishing sector. The programme is highly practical and includes break-out sessions using real project scenarios provided by delegates as well as providing publishing case studies as examples of what works and what doesn’t. It provides an excellent introduction for those new to taking responsibility for projects as well as a great refresher for those facing new project challenges. (full day)
If you're producing content for the web and want readers to find your products, you need to understand how to make search optimisation work for you. This course focuses on the practical things you can do, explains how search engines work, and equips you with the tools to apply all you have learnt immediately. (full day)
Event Date: November 19, 2014
This course will provide an insight into the technologies behind eJournal delivery. Technology has removed the barriers between production, editorial, marketing, sales, customer services and most importantly – the customers. The course will be business-centric – clearly positioning technologies in the context of the industry issues they aim to solve. Participants will learn how technology is used throughout the delivery of eJournals from publisher via library to the end-user. (full day)
Event Date: November 11, 2014
The US Center for Science in the Public Interest has questioned medical journals for not revealing the financial relationship the authors hold with drug companies for the studies that may potentially benefit the companies. . Scientists whose researches are funded by drug companies often publish their reports in prestigious scientific journals. Drug companies who fund the reports claim the results of the study while marketing the product. Publishers of the journals are left clueless about the funding agreement. Click Here
Allen Press had conducted an annual study to identify the pricing patterns of scientific and medical journals. The research covers the 2004 pricing of US journals and gives recommendations on the pricing structure for 2005. It carries comparisons between the pricing structures of non-profit society journals and discusses general pricing trends in the US. The author also ranks the journals based on the subscription charges and science categories with higher prices. The paper also forecasts the pricing strategy of science journals in 2005. Click Here
Researchers have voiced their support to Open Access (OA) that makes their works available to anyone free of cost. While commercial publishers have given a subdued response to OA, scientists welcome OA archiving, wherein institutions or academics maintain an electronic format of the studies submitted by the scientists. Amidst disapproval from publishers and scientific groups, OA archiving is gaining acceptance from developed nations. Economic factors, existing subsidised but limited free content supported by publishers and an inclination to traditional publishing are a few reasons that impede support for OA archiving from developing countries. Click Here
The “open access movement”, which is rapidly gaining ground in the area of STM publishing, stresses the free use of online medical research. As commercial publishers set high prices for medical periodicals and libraries struggle to sustain amidst shrinking budgets, a debate has flared up on the need for open access. Clinical and basic researchers point out that as these studies are funded by the government, the publishers must make them available for free. The increasing use of electronic format of journals has induced independent publishers, such as ASCO and JCO, to host e-journals as an extension of their respective membership programmes and educational missions. Click Here
The open access movement is gaining momentum. Critics have voiced their strong protests against the pricing of STM journals. The spiralling prices were, in fact, the major reason for the launch and rapid spreading of the open access movement. Does this mean the end of SRM publishers? No, says Bill Town in his article in Computing. Click Here
270 Madison Avenue,New York ,NY-10016-0602website
40 Salem Street,Lynnfield,MA-01940website
3501 Market Street,Philadelphia,PA-19104website
333 Seventh Avenue, 20th floor,New York ,NY -10001website
Chemical Abstracts Service
2540 Olentangy River Road, ,PO Box 3012, Columbus,OH-43210website